Characterization of Polybrominated Diphenyl Ether Toxicity in Wistar Han Rats and Use of Liver Microarray Data for Predicting Disease Susceptibilities

Toxicologic Pathology

Volumn 40, Issue 1, 2012, Pages 93-106

  Dunnick, J K ^a   Brix, A ^a   Cunny, H ^a   Vallant, M ^a   Shockley, K R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

lipid metabolism; liver toxicity; polybrominated diphenyl ethers

Indexed keywords

PHENOBARBITAL; POLYBROMINATED DIPHENYL ETHER; STEROL; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL VACUOLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEEDING; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; LIPID DIET; LIPID METABOLISM; LIVER HYPERTROPHY; LIVER TOXICITY; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGENY; PROTEIN MICROARRAY; RAT;

ANALYSIS OF VARIANCE; ANIMALS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; HALOGENATED DIPHENYL ETHERS; HISTOCYTOCHEMISTRY; LIPID METABOLISM; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR;

RATTUS; RODENTIA;

EID: 84856203412     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311429973     Document Type: Article

References (96)

1. Agency for Toxic Substances and Disease Registry (2004). Toxicological Profile for Polybrominated Biphenyls and Polybrominated Diphenyl Ethers (PBBs and PBDEs). http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=529&tid=94. Accessed April 2011.
2. Allen D. G. Pearse G. Haseman J. K. Maronpot R. R. (2004). Prediction of rodent carcinogenesis: An evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies. Toxicol Pathol 32, 393–401.
3. Almon R. R. DuBois D. C. Lai W. Xue B. Nie J. Jusko W. J. (2009). Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats. J Endocrinol 200, 331–46.
4. An J. Li S. Zhong Y. Wang Y. Zhen K. Zhang X. Wu M. Yu Z. Sheng G. Fu J. Huang Y. (2010). The cytotoxic effects of synthetic 6-hydroxylated and 6-methoxylated polybrominated diphenyl ether 47 (BDE47). Environ Toxicol [Epub ahead of print].
5. Ancona N. Maglietta R. Piepoli A. D’Addabbo A. Cotugno R. Savino M. Liuni S. Carella M. Pesole G. Perri F. (2006). On the statistical assessment of classifiers using DNA microarray data. BMC Bioinformatics 7, 387.
6. Auerbach S. S. Shah R. R. Mav D. Smith C. S. Walker N. J. Vallant M. K. Boorman G. A. Irwin R. D. (2009). Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning. Toxicol Appl Pharmacol 243, 300–14.
7. Baker J. L. Olsen L. W. Sorensen T. I. (2007). Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357, 2329–37.
8. Ballmaier D. Epe B. (2006). DNA damage by bromate: Mechanism and consequences. Toxicology 221, 166–71.
9. Birnbaum L. S. Cohen Hubal E. A. (2006). Polybrominated diphenyl ethers: A case study for using biomonitoring data to address risk assessment questions. Environ Health Perspect 114, 1770–75.
10. Boverhof D. R. Burgoon L. D. Tashiro C. Sharratt B. Chittim B. Harkema J. R. Mendrick D. L. Zacharewski T. R. (2006). Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol Sci 94, 398–416.
11. Boverhof D. R. Kwekel J. C. Humes D. G. Burgoon L. D. Zacharewski T. R. (2006). Dioxin induces an estrogen-like, estrogen receptor-dependent gene expression response in the murine uterus. Mol Pharmacol 69, 1599–606.
12. Butler W. H. (1978). Long-term effects of phenobarbitone-Na on male Fischer rats. Br J Cancer 37, 418–23.
13. Canton R. F. Sanderson J. T. Nijmeijer S. Bergman A. Letcher R. J. van den Berg M. (2006). In vitro effects of brominated flame retardants and metabolites on CYP17 catalytic activity: a novel mechanism of action? Toxicol Appl Pharmacol 216, 274–81.
14. Choksi N. Y. Jahnke G. D. St. Hilaire C. Shelby M. (2003). Role of thyroid hormones in human and laboratory animal reproductive health. Birth Defects Res B Dev Reprod Toxicol 68, 479–91.
15. Cui X. Hwang J. T. Qiu J. Blades N. J. Churchill G. A. (2005). Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics 6, 59–75.
16. Darnerud P. O. (2008). Brominated flame retardants as possible endocrine disrupters. Int J Androl 31, 152–60.
17. Darnerud P. O. Aune M. Larsson L. Hallgren S. (2007). Plasma PBDE and thyroxine levels in rats exposed to Bromkal or BDE-47. Chemosphere 67, S386–92.
18. Dunnick J. K. Heath J. E. Farnell D. R. Prejean J. D. Haseman J. K. Elwell M. R. (1997a). Carcinogenic activity of the flame retardant, 2,2-bis(bromomethyl)-1,3-propanediol in rodents, and comparison with the carcinogenicity of other NTP brominated chemicals. Toxicol Pathol 25, 541–48.
19. Dunnick J. Heath J. Farnell D. Prejean J. Haseman J. Elwell M. R. (1997b). Carcinogenic activity of the flame retardant, 2,2-bis(bromomethyl)-1,3-propanediol in rodents, and comparison with the carcinogenicity of other NTP brominated chemicals. Toxicol Pathol 25, 541–48.
20. Dunnick J. K. Nyska A. (2009). Characterization of liver toxicity in F344/N rats and B6C3F1 mice after exposure to a flame retardant containing lower molecular weight polybrominated diphenyl ethers. Exp Toxicol Pathol 61, 1–12.
21. Ellis E. M. (2007). Reactive carbonyls and oxidative stress: Potential for therapeutic intervention. Pharmacol Ther 115, 13–24.
22. Ellis-Hutchings R. G. Cherr G. N. Hanna L. A. Keen C. L. (2006). Polybrominated diphenyl ether (PBDE)-induced alterations in vitamin A and thyroid hormone concentrations in the rat during lactation and early postnatal development. Toxicol Appl Pharmacol 215, 135–45.
23. Ervin R. B. (2009). Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report 5, 1–7.
24. Eustis S. L. Boorman G. A. Harada T. Popp J. A. (1990). Liver. In Pathology of the Fischer Rat (Boorman G. A. Eustis S. L. Elwell M. R. Montgomery C. A. Jr. MacKenzie W. F., eds.), pp. 78–81. Academic Press Inc., New York, NY.
25. Frau M. Biasi F. Feo F. Pascale R. M. (2010). Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. Mol Aspects Med 31, 179–93.
26. Frederiksen M. Thomsen C. Froshaug M. Vorkamp K. Thomsen M. Becher G. Knudsen L. E. (2010). Polybrominated diphenyl ethers in paired samples of maternal and umbilical cord blood plasma and associations with house dust in a Danish cohort. Int J Hyg Environ Health 213, 233–42.
27. Gautier L. Cope L. Bolstad B. M. Irizarry R. A. (2004). affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307–15.
28. Hale R. C. Alaee M. Manchester-Neesvig J. B. Stapleton H. M. Ikonomou M. G. (2003). Polybrominated diphenyl ether flame retardants in the North American environment. Environ Int 29, 771–79.
29. Hale R. C. La Guardia M. J. Harvey E. Mainor T. M. (2002). Potential role of fire retardant-treated polyurethane foam as a source of brominated diphenyl etheres to the U. S. environment. Chemosphere 46, 729–35.
30. Hale R. C. La Guardia M. J. Harvey E. P. Gaylor M. O. Mainor T. M. Duff W. H. (2001). Persistant pollutants in land-applied sludges. Nature 412, 140–41.
31. Hamers T. Kamstra J. H. Sonneveld E. Murk A. J. Kester M. H. Andersson P. L. Legler J. Brouwer A. (2006). In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol Sci 92, 157–73.
32. Harley K. G. Marks A. R. Chevrier J. Bradman A. Sjodin A. Eskenazi B. (2010). PBDE concentrations in women's serum and fecundability. Environ Health Perspect 118, 699–704.
33. Harper M. E. Seifert E. L. (2008). Thyroid hormone effects on mitochondrial energetics. Thyroid 18, 145–56.
34. Harrad S. Goosey E. Desborough J. Abdallah M. A. Roosens L. Covaci A. (2010). Dust from U.K. primary school classrooms and daycare centers: The significance of dust as a pathway of exposure of young U.K. children to brominated flame retardants and polychlorinated biphenyls. Environ Sci Technol 44, 4198–202.
35. Hofland J. van Weerden W. M. Dits N. F. Steenbergen J. van Leenders G. J. Jenster G. Schroder F. H. de Jong F. H. (2010). Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer. Cancer Res 70, 1256–64.
36. Hoppe A. A. Carey G. B. (2007). Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism. Obesity (Silver Spring) 15, 2942–50.
37. Imaida K. Wang C. Y. (1986). Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats. Cancer Res 46, 6160–64.
38. Irizarry R. A. Ladd-Acosta C. Wen B. Wu Z. Montano C. Onyango P. Cui H. Gabo K. Rongione M. Webster M. Ji H. Potash J. B. Sabunciyan S. Feinberg A. P. (2009). The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41, 178–86.
39. Irizarry R. A. Bolstad B. M. Collin F. Cope L. M. Hobbs B. Speed T. P. (2003). Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31, e15.
40. Jahnke G. D. Choksi N. Y. Moore J. A. Shelby M. D. (2004). Thyroid toxicants: Assessing reproductive health effects. Environ Health Perspect 112, 363–68.
41. Jin S. Yang F. Hui Y. Xu Y. Lu Y. Liu J. (2010). Cytotoxicity and apoptosis induction on RTG-2 cells of 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47) and decabrominated diphenyl ether (BDE-209). Toxicol In Vitro 24, 1190–96.
42. Johnson P. I. Stapleton H. M. Sjodin A. Meeker J. D. (2010). Relationships between polybrominated diphenyl ether concentrations in house dust and serum. Environ Sci Technol 44, 5627–32.
43. Jorissen R. N. Lipton L. Gibbs P. Chapman M. Desai J. Jones I. T. Yeatman T. J. East P. Tomlinson I. P. Verspaget H. W. Aaltonen L. A. Kruhoffer M. Orntoft T. F. Andersen C. L. Sieber O. M. (2008). DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers. Clin Cancer Res 14, 8061–69.
44. R.,M., Kleemann, van Erk, Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance, PLoS One, (2010), 5, 1, e8817
45. Koliadi A. Nilsson C. Holmqvist M. Holmberg L. de La Torre M. Warnberg F. Fjallskog M. L. (2010). Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer. Acta Oncol 49, 816–20.
46. Kupershmidt I. Su Q. J. Grewal A. Sundaresh S. Halperin I. Flynn J. Shekar M. Wang H. Park J. Cui W. Wall G. D. Wisotzkey R. Alag S. Akhtari S. Ronaghi M. (2010). Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 5.
47. Lee M. H. Hong I. Kim M. Lee B. H. Kim J. H. Kang K. S. Kim H. L. Yoon B. I. Chung H. Kong G. Lee M. O. (2008). Gene expression profiles of murine fatty liver induced by the administration of methotrexate. Toxicology 249, 75–84.
48. Lee M. H. Kim J. W. Kim J. H. Kang K. S. Kong G. Lee M. O. (2010). Gene expression profiling of murine hepatic steatosis induced by tamoxifen. Toxicol Lett 199, 416–24.
49. Legler J. Brouwer A. (2003). Are brominated flame retardants endocrine disruptors? Environ Int 29, 879–85.
50. Leigh-Brown S. Enriquez J. A. Odom D. T. (2010). Nuclear transcription factors in mammalian mitochondria. Genome Biol 11, 215.
51. Lim J. S. Lee D. H. Jacobs D. R., Jr. (2008). Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population, 2003–2004. Diabetes Care 31, 1802–7.
52. Lopaschuk G. D. Ussher J. R. Folmes C. D. Jaswal J. S. Stanley W. C. (2010). Myocardial fatty acid metabolism in health and disease. Physiol Rev 90, 207–58.
53. Lorber M. (2008). Exposure of Americans to polybrominated diphenyl ethers. J Expo Sci Environ Epidemiol 18, 2–19.
54. Lucero D. Zago V. Lopez G. I. Graffigna M. Lopez G. H. Fainboim H. Miksztowicz V. Rosso L. G. Belli S. Levalle O. Berg G. Brites F. Wikinski R. Schreier L. (2011). Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome? Clin Chim Acta 412, 587–92.
55. Maronpot R. Yoshizawa K. Nyska A. Harada T. Flake G. Muyeller G. Singh B. Ward J. (2010). Hepatic enzyme induction: Histopathology. Toxicol Pathol 38, 776–95.
56. Meerts I. A. Letcher R. J. Hoving S. Marsh G. Bergman A. Lemmen J. G. van der Burg B. Brouwer A. (2001). In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds. Environ Health Perspect 109, 399–407.
57. Mercado-Feliciano M. Bigsby R. M. (2008a). Hydroxylated metabolites of the polybrominated diphenyl ether mixture DE-71 are weak estrogen receptor-alpha ligands. Environ Health Perspect 116, 1315–21.
58. Mercado-Feliciano M. Bigsby R. M. (2008b). The polybrominated diphenyl ether mixture DE-71 is mildly estrogenic. Environ Health Perspect 116, 605–11.
59. Miller M. D. Crofton K. M. Rice D. C. Zoeller R. T. (2009). Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect 117, 1033–41.
60. N'Jai A. Boverhof D. R. Dere E. Burgoon L. D. Tan Y. S. Rowlands J. C. Budinsky R. A. Stebbins K. E. Zacharewski T. R. (2008). Comparative temporal toxicogenomic analysis of TCDD- and TCDF-mediated hepatic effects in immature female C57BL/6 mice. Toxicol Sci 103, 285–97.
61. National Toxicology Program (2004). Bulk chemical comprehensive analysis report-technical pentabromodiphenyl oxide. Battelle Report 7-173-BCCA-24, December 31, 2003.
62. National Toxicology Program (2005a). Three-month toxicity study of a pentabromodiphenyl oxide mixture (DE-71) administered by gavage to B6C3FI mice. Southern Research Institute Contract Report, Study number C20209, 11052.01.02 NTP Contract No. No1-ES-45516.
63. National Toxicology Program (2005b). Three-month toxicity study of a pentabromodiphenyl oxide mixture (DE-71) administered by gavage to Fischer-344 rats. Southern Research Institute Contract Report, Study number C20209, 11052.01.02 NTP Contract No. N01-ES-45516.
64. Nesnow S. Ward W. Moore T. Ren H. Hester S. D. (2009). Discrimination of tumorigenic triazole conazoles from phenobarbital by transcriptional analyses of mouse liver gene expression. Toxicol Sci 110, 68–83.
65. Office of Laboratory Animal Welfare, National Institutes of Health, Department of Health and Human Services. U. S. Public Health Service Policy on Humane Care and Use of Laboratory Animals. http://grants.nih.gov/grants/olaw/olaw.htm#pol. Accessed April 2011.
66. Pedrelli M. Pramfalk C. Parini P. (2010). Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport. World J Gastroenterol 16, 5958–64.
67. Petreas M. She J. Brown F. R. Winkler J. Windham G. Rogers E. Zhao G. Bhatia R. Charles M. J. (2003). High body burdens of 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47) in California women. Environ Health Perspect 111, 1175–79.
68. Rendic S. Guengerich F. P. (2010). Update information on drug metabolism systems--2009, part I. Curr Drug Metab 11, 4–84.
69. Richardson V. M. Staskal D. F. Ross D. G. Diliberto J. J. DeVito M. J. Birnbaum L. S. (2008). Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener. Toxicol Appl Pharmacol 226, 244–50.
70. Rossi L. Ravera M. Repetti G. Santi L. (1977). Long-term administration of DDT or phenobarbital-Na in Wistar rats. Int J Cancer 19, 179–85.
71. Roze E. Meijer L. Bakker A. Van Braeckel K. N. Sauer P. J. Bos A. F. (2009). Prenatal exposure to organohalogens, including brominated flame retardants, influences motor, cognitive, and behavioral performance at school age. Environ Health Perspect 117, 1953–58.
72. Saaf A. M. Halbleib J. M. Chen X. Yuen S. T. Leung S. Y. Nelson W. J. Brown P. O. (2007). Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol Biol Cell 18, 4245–60.
73. Sanders J. M. Burka L. T. Smith C. S. Black W. James R. Cunningham M. L. (2005). Differential expression of CYP1A, 2B, and 3A genes in the F344 rat following exposure to a polybrominated diphenyl ether mixture or individual components. Toxicol Sci 88, 127–33.
74. Schecter A. Colacino J. Sjodin A. Needham L. Birnbaum L. (2010). Partitioning of polybrominated diphenyl ethers (PBDEs) in serum and milk from the same mothers. Chemosphere 78, 1279–84.
75. Schecter A. Papke O. Harris T. R. Tung K. C. Musumba A. Olson J. Birnbaum L. (2006). Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex. Environ Health Perspect 114, 1515–20.
76. Sjodin A. Jones R. S. Focant J. F. Lapeza C. Wang R. Y. McGahee E. E. I. Zhang Y. Turner W. E. Slazyk B. Needham L. L. Patterson D. G. Jr. (2004). Retrospective time trend study of polybrominate diphenyl ether and polybrominated and polychlorineated biphenyl levels in human serum form the United States. Environ Health Perspect 112, 654–58.
77. Song R. He Y. Murphy M. B. Yeung L. W. Yu R. M. Lam M. H. Lam P. K. Hecker M. Giesy J. P. Wu R. S. Zhang W. Sheng G. Fu J. (2008). Effects of fifteen PBDE metabolites, DE71, DE79 and TBBPA on steroidogenesis in the H295R cell line. Chemosphere 71, 1888–94.
78. Stephens P. J. Greenman C. D. Fu B. Yang F. Bignell G. R. Mudie L. J. Pleasance E. D. Lau K. W. Beare D. Stebbings L. A. McLaren S. Lin M. L. McBride D. J. Varela I. Nik-Zainal S. Leroy C. Jia M. Menzies A. Butler A. P. Teague J. W. Quail M. A. Burton J. Swerdlow H. Carter N. P. Morsberger L. A. Iacobuzio-Donahue C. Follows G. A. Green A. R. Flanagan A. M. Stratton M. R. Futreal P. A. Campbell P. J. (2011). Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40.
79. Stickel F. Hellerbrand C. (2010). Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: Mechanisms and implications. Gut 59, 1303–7.
80. Suvorov A. Takser L. (2010). Global gene expression analysis in the livers of rat offspring perinatally exposed to low doses of 2,2′,4,4′-tetrabromodiphenyl ether. Environ Health Perspect 118, 97–102.
81. Szabo D. T. Richardson V. M. Ross D. G. Diliberto J. J. Kodavanti P. R. Birnbaum L. S. (2009). Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups. Toxicol Sci 107, 27–39.
82. Talsness C. E. Kuriyama S. N. Sterner-Kock A. Schnitker P. Grande S. W. Shakibaei M. Andrade A. Grote K. Chahoud I. (2008). In utero and lactational exposures to low doses of polybrominated diphenyl ether-47 alter the reproductive system and thyroid gland of female rat offspring. Environ Health Perspect 116, 308–14.
83. Tanaka S. Arii S. (2010). Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science. Int J Clin Oncol 15, 235–41.
84. Teoh N. C. (2009). Proliferative drive and liver carcinogenesis: too much of a good thing? J Gastroenterol Hepatol 24, 1817–25.
85. U.S. Environmental Protection Agency (2008a). Toxicological review of 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47). http://www.epa.gov/NCEA/iris/. Accessed April 2011.
86. U.S. Environmental Protection Agency (2008b). Toxicological Review of 2,2′,4,4′,5,5′-hexabromodiphenyl ether (BDE-153). http://www.epa.gov/NCEA/iris/.
87. U.S. Environmental Protection Agency (2008c). Toxicological Review of 2,2′.4,4′,5-pentabromodiphenyl ether (BDE-99). http://www.epa.gov/NCEA/iris/.
88. U.S. Environmental Protection Agency (2008d). Toxicological Review of Decabromodiphenyl ether (BDE-209). http://www.epa.gov/NCEA/iris/.
89. U.S. Environmental Protection Agency (2009). Chemical hazard review: furniture flame retardancy partnership: Environmental profiles of chemical flame-retardant alternatives for low-density polyurethane foam. http://www.epa.gov/dfe1.
90. U.S. Environmental Protection Agency (2010). An exposure assessment of polybrominated diphenyl ethers. National Center for Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC. http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=210404#Download.
91. Waterman C. L. Currie R. A. Cottrell L. A. Dow J. Wright J. Waterfield C. J. Griffin J. L. (2010). An integrated functional genomic study of acute phenobarbital exposure in the rat. BMC Genomics 11, 9.
92. World Health Organization (2003). Health risks of persistent organic pollutants from long-range transboundary air pollution. In pp. 199–212.
93. Wu H. Kerr M. K. Cui X. Q. Churchill G. A. (2003). MAANOVA: A software package for the analysis of spotted cDNA microarray experiments. In Analysis of Gene Expression Data: An Overview of Methods and Software (Parmgiani G. Garret E. S. Irizarry R. A. Zeger S. L., eds.), pp. 313–41. Springer, New York, NY.
94. Yang X. Zhang B. Molony C. Chudin E. Hao K. Zhu J. Gaedigk A. Suver C. Zhong H. Leeder J. S. Guengerich F. P. Strom S. C. Schuetz E. Rushmore T. H. Ulrich R. G. Slatter J. G. Schadt E. E. Kasarskis A. Lum P. Y. (2010). Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res 20, 1020–36.
95. Yanovski S. Z. Yanovski J. A. (2002). Obesity. N Engl J Med 346, 591–602.
96. Zhou T. Taylor M. M. DeVito M. J. Crofton K. M. (2002). Developmental exposure to brominated diphenyl etheres results in thyroid hormone disruption. Toxicol Sci 66, 105–16.